These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3668203)

  • 1. Side effects of transdermal scopolamine.
    Wilkinson JA
    J Emerg Med; 1987; 5(5):389-92. PubMed ID: 3668203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Scopoderm depot plasters--confusions and hallucinations].
    Kjeldaas L
    Tidsskr Nor Laegeforen; 1986 Feb; 106(5):436-7. PubMed ID: 3961766
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic effects of scopolamine eye drops.
    Freund M; Merin S
    Am J Ophthalmol; 1970 Oct; 70(4):637-9. PubMed ID: 5505483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

  • 5. Central anticholinergic syndrome in a pediatric patient following transdermal scopolamine patch placement.
    Holland MS
    Nurse Anesth; 1992 Sep; 3(3):121-4. PubMed ID: 1445954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
    Rubner O; Kummerhoff PW; Haase H
    Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine withdrawal syndrome.
    Saxena K; Saxena S
    Postgrad Med; 1990 Jan; 87(1):63-6. PubMed ID: 2296571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal scopolamine-induced psychosis.
    Ziskind AA
    Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
    Attias J; Gordon C; Ribak J; Binah O; Rolnick A
    Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
    Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
    Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI).
    Seo SW; Suh MK; Chin J; Na DL
    Arch Gerontol Geriatr; 2009; 49(2):204-207. PubMed ID: 18834638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 14. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal scopolamine use in the control of narcotic-induced nausea.
    Ferris FD; Kerr IG; Sone M; Marcuzzi M
    J Pain Symptom Manage; 1991 Aug; 6(6):389-93. PubMed ID: 1880439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual side-effects from transdermal scopolamine (hyoscine).
    Firth AY; Walker K
    Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Dahl E; Offer-Ohlsen D; Lillevold PE; Sandvik L
    Clin Pharmacol Ther; 1984 Jul; 36(1):116-20. PubMed ID: 6734040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transcutaneous scopolamine and depth on diver performance.
    Williams TH; Wilkinson AR; Davis FM; Frampton CM
    Undersea Biomed Res; 1988 Mar; 15(2):89-98. PubMed ID: 3363755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.